Korea Investment Corp’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$106M Buy
213,312
+12,144
+6% +$5.38M 0.2% 84
2026
Q1
$89.8M Buy
201,168
+7,733
+4% +$3.61M 0.19% 98
2025
Q4
$87.7M Sell
193,435
-12,310
-6% -$5.31M 0.17% 105
2025
Q3
$80.6M Buy
205,745
+4,011
+2% +$1.68M 0.17% 113
2025
Q2
$89.8M Sell
201,734
-19,446
-9% -$8.96M 0.2% 97
2025
Q1
$107M Buy
221,180
+14,072
+7% +$6.56M 0.26% 74
2024
Q4
$83.4M Sell
207,108
-14,438
-7% -$6.69M 0.2% 91
2024
Q3
$103M Buy
221,546
+6,746
+3% +$3.24M 0.24% 83
2024
Q2
$101M Sell
214,800
-23,977
-10% -$10.4M 0.25% 75
2024
Q1
$99.8M Sell
238,777
-64,062
-21% -$27.1M 0.25% 80
2023
Q4
$123M Buy
302,839
+22,498
+8% +$8.31M 0.32% 59
2023
Q3
$97.5M Sell
280,341
-74,430
-21% -$26M 0.29% 76
2023
Q2
$125M Sell
354,771
-15,209
-4% -$5.12M 0.35% 56
2023
Q1
$117M Buy
369,980
+11,709
+3% +$3.51M 0.34% 68
2022
Q4
$103M Buy
358,271
+2,257
+0.6% +$688K 0.33% 78
2022
Q3
$103M Buy
356,014
+51,315
+17% +$14.8M 0.32% 67
2022
Q2
$85.9M Buy
304,699
+52,490
+21% +$14M 0.26% 89
2022
Q1
$65.8M Buy
252,209
+28,512
+13% +$6.77M 0.16% 151
2021
Q4
$49.1M Buy
223,697
+78,111
+54% +$15.2M 0.13% 182
2021
Q3
$26.4M Sell
145,586
-80,615
-36% -$15.7M 0.08% 229
2021
Q2
$45.6M Buy
226,201
+4,414
+2% +$923K 0.13% 182
2021
Q1
$47.7M Buy
221,787
+69,556
+46% +$15.3M 0.15% 167
2020
Q4
$36M Sell
152,231
-40,569
-21% -$9.31M 0.11% 197
2020
Q3
$52.5M Buy
192,800
+5,000
+3% +$1.38M 0.19% 151
2020
Q2
$54.5M Buy
187,800
+6,300
+3% +$1.71M 0.2% 132
2020
Q1
$43.2M Buy
181,500
+14,700
+9% +$3.37M 0.19% 148
2019
Q4
$36.5M Sell
166,800
-11,900
-7% -$2.41M 0.13% 185
2019
Q3
$30.3M Sell
178,700
-8,800
-5% -$1.56M 0.13% 193
2019
Q2
$34.4M Buy
187,500
+34,900
+23% +$6.1M 0.15% 172
2019
Q1
$28.1M Buy
152,600
+5,585
+4% +$1.03M 0.13% 191
2018
Q4
$24.4M Sell
147,015
-10,900
-7% -$1.89M 0.13% 190
2018
Q3
$30.4M Sell
157,915
-14,387
-8% -$2.56M 0.14% 182
2018
Q2
$29.3M Buy
172,302
+48,300
+39% +$7.49M 0.13% 191
2018
Q1
$20.2M Buy
124,002
+19,200
+18% +$3.14M 0.09% 240
2017
Q4
$15.7M Sell
104,802
-9,200
-8% -$1.36M 0.07% 267
2017
Q3
$17.3M Buy
114,002
+800
+0.7% +$120K 0.08% 236
2017
Q2
$14.6M Buy
113,202
+112,252
+11,816% +$13.5M 0.07% 265
2017
Q1
$104K Buy
950
+658
+225% +$57.9K ﹤0.01% 600
2016
Q4
$22K Buy
+292
New +$23.8K ﹤0.01% 570
2016
Q2
Sell
-127,758
Closed -$10.2M 579
2016
Q1
$10.2M Sell
127,758
-22,800
-15% -$2.06M 0.07% 249
2015
Q4
$18.9M Buy
150,558
+34,600
+30% +$4.18M 0.13% 182
2015
Q3
$12.1M Buy
115,958
+9,558
+9% +$1.23M 0.1% 218
2015
Q2
$13.1M Sell
106,400
-18,200
-15% -$2.29M 0.11% 201
2015
Q1
$14.7M Sell
124,600
-126,100
-50% -$15.1M 0.11% 193
2014
Q4
$29.8M Buy
250,700
+40,200
+19% +$4.53M 0.24% 107
2014
Q3
$23.6M Buy
210,500
+133,800
+174% +$12.7M 0.19% 124
2014
Q2
$7.26M Buy
76,700
+32,100
+72% +$2.25M 0.06% 312
2014
Q1
$3.15M Sell
44,600
-108,700
-71% -$8.61M 0.03% 453
2013
Q4
$11.4M Sell
153,300
-107,900
-41% -$7.51M 0.11% 209
2013
Q3
$19.8M Buy
261,200
+254,200
+3,631% +$20.2M 0.21% 118
2013
Q2
$559K Buy
+7,000
New +$516K 0.01% 556

Other funds holding VRTX

Korea Investment Corp's VRTX Position: Q2 2026 in Review

Korea Investment Corp increased its Vertex Pharmaceuticals (VRTX) stake by 6% in Q2 2026, buying an estimated $5.38M and bringing the position to 213,312 shares worth $106M. The position accounts for 0.2% of the portfolio, ranked #84.

Korea Investment Corp first reported a position in VRTX in Q2 2013 and has held it in 51 quarters since. The position peaked at $125M in Q2 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Korea Investment Corp held 213,312 shares of Vertex Pharmaceuticals worth $106M as of Q2 2026.
  • Korea Investment Corp bought 12,144 Vertex Pharmaceuticals shares in Q2 2026, an estimated $5.38M.
  • Vertex Pharmaceuticals made up 0.2% of Korea Investment Corp's portfolio in Q2 2026, its #84 holding.
  • Korea Investment Corp first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
  • Korea Investment Corp's Vertex Pharmaceuticals position peaked at $125M in Q2 2023.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.